Evaluating Ebola vaccine trials: insights from simulation

Affiliations

¹ Department of Biology and Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA. Electronic address: pulliam@ufl.edu.
² Center for Computational Biology and Bioinformatics, The University of Texas at Austin, Austin, TX, USA.
³ Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia; Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
⁴ Department of Integrative Biology, The University of Texas at Austin, Austin, TX, USA; The Santa Fe Institute, Santa Fe, NM, USA.
⁵ Department of Biology, McMaster University, Hamilton, ON, Canada.

Comment

Juliet R C Pulliam et al. Lancet Infect Dis. 2015 Oct.

. 2015 Oct;15(10):1134.

doi: 10.1016/S1473-3099(15)00303-5. Epub 2015 Sep 20.

¹ Department of Biology and Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA. Electronic address: pulliam@ufl.edu.
² Center for Computational Biology and Bioinformatics, The University of Texas at Austin, Austin, TX, USA.
³ Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia; Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
⁴ Department of Integrative Biology, The University of Texas at Austin, Austin, TX, USA; The Santa Fe Institute, Santa Fe, NM, USA.
⁵ Department of Biology, McMaster University, Hamilton, ON, Canada.

No abstract available

Conflict of interest statement

The authors declare no conflicts of interest.

Stepped-wedge trial design to evaluate Ebola treatments.
Piszczek J, Partlow E. Piszczek J, et al. Lancet Infect Dis. 2015 Jul;15(7):762-3. doi: 10.1016/S1473-3099(15)00078-X. Lancet Infect Dis. 2015. PMID: 26122441 No abstract available.

1. Piszczek J, Parlow E. Stepped-wedge trial design to evaluate Ebola treatments. Lancet Infect Dis. 2015;15:762–63. - PubMed
1. Centers for Disease Control and Prevention. Sierra Leone to Introduce a Vaccine against Ebola (STRIVE) 2015 Apr 14; www.cdc.gov/vhf/ebola/strive/qa.html (accessed July 2, 2015)
1. Bellan SE, Pulliam JRC, Pearson CAB, et al. Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis. Lancet Infect Dis. 2015;15:703–10. - PMC - PubMed
1. Tully C, Lambe T, Gilbert S, et al. Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases. Lancet Infect Dis. 2015;15:356–59. - PubMed
1. Hussey M, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2007;28:182–91. - PubMed